NCT04532424View on ClinicalTrials.gov

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

NARecruitingINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

December 1, 2029

Study Completion Date

December 1, 2029

Conditions
Autism Spectrum DisorderAutismAsperger Syndrome
Interventions
DEVICE

Transcranial magnetic stimulation

Non-invasive brain stimulation technique that is FDA-approved for the treatment of refractory depression, OCD and migraine.

Trial Locations (1)

94305-5719

RECRUITING

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER